论文信息 - The plasmablast response to SARS-CoV-2 mRNA vaccination is dominated by non-neutralizing 1 antibodies and targets both the NTD and the RBD 2 - 字舞流文

The plasmablast response to SARS-CoV-2 mRNA vaccination is dominated by non-neutralizing 1 antibodies and targets both the NTD and the RBD 2

F. Krammer | G. Bajic | A. Ellebedy | F. Amanat | J. Turner | A. Schmitz | E. Sordillo | D. Altman | Wajnberg | Rachel Chernet | J. M. Carreño | D. Jurczyszak | D. C. Adelsberg | E. Ferreri | D. Floda | J. Matthews | H. Alshammary | H. Bakel | Mahima Thapa | A. Amoako | Lily Q. Eaker | S. Fabre | Willemijn Rijnink | K. Beach | Mahmoud H. Awawda | S. Zafar | Ana Gonzalez Reiche | Carolina Bermúdez-González | Viviana Simon | Nicholas Borcherding | Shirin Strohmeier | CF Lubbertus | Ashley-Beathrese Russo | Levy A Shin | Tinting Lei | S. Ahmed | K. Srivastava | Julian Q. Zhou | The Personalized | Virology Initiative | Dr. Bulbul Ahmed | Dr Charles Gleason | Dr Giulio Kleiner | Dr Wanni Mendez | Jose Mulder | P. Kayla | Dr. Miti Salimbangon | Amber S Saksena | Sayahi Sominsky | Dr Ania Suthakaran